Most Popular Stories
- Walgreens plans 100 more retail clinics by mid-2009
- Disruptive doctor behavior causes mistakes, intimidates workers
- AHA survey: Negative profit margins for hospitals
- DOD, VA move to SOA architecture to build interoperable systems
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- Cleveland Clinic lists potential conflicts of interest online
Poll
Featured Jobs
-
California Director of Women's Health
StaffPointe, LLC - San Francisco , CA -
Wisonsin-General Surgeon
Ohrmund Employment Group - Cedarburg, WI -
Florida Noninvasive Cardiologist
StaffPointe, LLC - west , FL -
Arizona Nurse Practitioner
StaffPointe, LLC - southwest , AZ -
CA Nursing Direct. Medical/Telemetry
StaffPointe, LLC - San Francisco , CA
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
- Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey
Popular Topics
FDA warns Mayfield Clinic MD over study problems
A Mayfield Clinic neurosurgeon has gotten an FDA warning letter alleging that problems with record-keeping, reporting of adverse events and enrollment of patients in a study he was conducting. The FDA asserts that Dr. William Tobler and his team didn't document adequately that subjects were screened for study eligibility, kept inaccurate records and post-dated reports years after the fact. It also contends that Tobler did too little to respond to an earlier FDA critique of how the research was managed.
The study, which took place between May 2003 and August 2006, was part of a multi-center trial comparing a device used in spinal fusions for disk degeneration to other approaches. During the study, seven patients received the device, and all fared well, the clinic said in a press statement.
To learn more about the warning:
- read this Business Courier of Cincinnati piece
Related Stories
- FDA contact number may be on DTC ads soon; Critics speak out against New Orleans medical campus;
- Study: Medicaid paid $198 million for unapproved drugs
- FDA investigated for improper review of medical devices
- FDA's medical approval process faces GAO scrutiny
- FDA needs to inspect more foreign drugs, GAO finds
- Eli Lilly to pay $62M to settle Zyprexa marketing charges
- Boston ends Canadian drug import program, citing lack of interest
- Study: Pain doctors rarely sanctioned for narcotic prescriptions
- Supreme Court to consider 'pre-emption' for drug companies
- FDA may urge training to dispense narcotics
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





